CAPPED BONUSZERTIFIKAT - PFIZER INC Share Price

Certificat

DE000PN7MYR9

Market Closed - Deutsche Boerse AG 20:40:15 31/05/2024 BST
31.04 EUR +2.65% Intraday chart for CAPPED BONUSZERTIFIKAT - PFIZER INC
1 month+29.28%
3 months+18.79%
Date Price Change
31/05/24 31.04 +2.65%
30/05/24 30.24 +0.43%
29/05/24 30.11 -1.79%
28/05/24 30.66 -4.07%
27/05/24 31.96 +1.14%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 08:40 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7MYR
ISINDE000PN7MYR9
Date issued 21/08/2023
Strike 42 $
Maturity 20/12/2024 (201 Days)
Parity 1 : 1
Emission price 32.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 33.88
Lowest since issue 23.23

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66 USD
Average target price
31.92 USD
Spread / Average Target
+11.36%
Consensus